# The Effect of Improved Glycemic Control on the Composition and Function of High-Density Lipoproteins (HDL) in Patients With Type 1 Diabetes

> **NCT07564752** · — · RECRUITING · sponsor: **Centre Hospitalier Universitaire Dijon** · enrollment: 143 (estimated)

## Conditions studied

- Type 1 Diabetes

## Interventions

- **BIOLOGICAL:** Blood test
- **BIOLOGICAL:** Urine sample

## Key facts

- **NCT ID:** NCT07564752
- **Lead sponsor:** Centre Hospitalier Universitaire Dijon
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-02-25
- **Primary completion:** 2027-11
- **Final completion:** 2027-11
- **Target enrollment:** 143 (ESTIMATED)
- **Last updated:** 2026-05-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07564752

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07564752, "The Effect of Improved Glycemic Control on the Composition and Function of High-Density Lipoproteins (HDL) in Patients With Type 1 Diabetes". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT07564752. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*